PMID- 35383557 OWN - NLM STAT- MEDLINE DCOM- 20230125 LR - 20231228 IS - 0392-856X (Print) IS - 0392-856X (Linking) VI - 41 IP - 1 DP - 2023 Jan TI - Long-term evaluation of pulmonary function and survival of patients with interstitial pneumonia with autoimmune features. PG - 15-23 LID - 10.55563/clinexprheumatol/tdueis [doi] AB - OBJECTIVES: Interstitial pneumonia with autoimmune features (IPAF) includes patients with interstitial lung disease with autoimmune features who do not meet criteria for a connective tissue disease (CTD). Previous studies showed a wide variation in the radiologic pattern, pulmonary function and prognosis but there is still limited data on longitudinal outcomes. We aim to describe the long-term pulmonary function, radiological patterns, and survival of IPAF patients and explore a classification based on CTD-like subgroups by using clinical/serologic data. METHODS: Retrospective analysis of IPAF patients who were sub-classified into six CTD-(like) subgroups: systemic lupus erythematosus-like, rheumatoid arthritis-like, Sjogren's syndrome-like, scleroderma, myositis-like, and unclassifiable. Linear mixed-effect models were used to compare the change in percent-predicted forced vital capacity (FVC%), percent-predicted diffusion capacity (DLCO%), and six-minute walk distance (SMWD) over time; and survival in the entire cohort and according to CTD-like subgroups and radiological patterns. RESULTS: Fifty-nine patients fulfilled IPAF criteria. FVC%, DLCO%, and SMWD remained stable over time. There was no difference between usual interstitial pneumonia (UIP) versus non-UIP radiologic patterns. Thirty-five patients were sub-classified into CTD-like subgroups. Survival decreased from 79% at 60 months to 53% at 120 months in the entire cohort but was similar among CTD-like subgroups and radiological patterns. CONCLUSIONS: Long-term pulmonary function and six-minute walk test remained stable over 36 months in our IPAF cohort. Prognosis and pulmonary function in UIP had similar outcomes compared to non-UIP. Although 40% of IPAF patients could not be sub-classified, our exploratory subclassification stratified 60% of patients into a CTD-like subgroup. FAU - Huapaya, Julio A AU - Huapaya JA AD - Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA. FAU - Boulougoura, Afroditi AU - Boulougoura A AD - Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, MA, USA. FAU - Fried, Julie AU - Fried J AD - Division of Pulmonary, Critical Care and Sleep Medicine, MedStar Georgetown University Hospital, Washington, DC, USA. FAU - Mesdaghinia, Sepehr AU - Mesdaghinia S AD - Division of Rheumatology, MedStar Georgetown University Hospital, Washington, DC, USA. FAU - Culotta, Brooks J AU - Culotta BJ AD - Division of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University School of Medicine, New Orleans, LA, USA. FAU - Carson, Sara AU - Carson S AD - Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. FAU - Bergquist, Peter J AU - Bergquist PJ AD - Department of Radiology, MedStar Georgetown University Hospital, Washington, DC, USA. FAU - Krishnan, Pranay AU - Krishnan P AD - Department of Radiology, MedStar Georgetown University Hospital, Washington, DC, USA. FAU - Wang, Haijun AU - Wang H AD - Department of Biostatistics and Biomedical Informatics. Medstar Health Research Institute, Hyattsville, MD, USA. FAU - Reichner, Cristina AU - Reichner C AD - Division of Pulmonary, Critical Care and Sleep Medicine, MedStar Georgetown University Hospital, Washington, DC, USA. FAU - Steen, Virginia AU - Steen V AD - Division of Rheumatology, MedStar Georgetown University Hospital, Washington, DC, USA. steenv@georgetown.edu. LA - eng PT - Journal Article DEP - 20220330 PL - Italy TA - Clin Exp Rheumatol JT - Clinical and experimental rheumatology JID - 8308521 SB - IM MH - Humans MH - Retrospective Studies MH - *Lung Diseases, Interstitial MH - Lung MH - *Idiopathic Pulmonary Fibrosis MH - *Connective Tissue Diseases MH - *Autoimmune Diseases EDAT- 2022/04/07 06:00 MHDA- 2023/01/26 06:00 CRDT- 2022/04/06 09:01 PHST- 2021/11/28 00:00 [received] PHST- 2022/02/07 00:00 [accepted] PHST- 2022/04/07 06:00 [pubmed] PHST- 2023/01/26 06:00 [medline] PHST- 2022/04/06 09:01 [entrez] AID - 18161 [pii] AID - 10.55563/clinexprheumatol/tdueis [doi] PST - ppublish SO - Clin Exp Rheumatol. 2023 Jan;41(1):15-23. doi: 10.55563/clinexprheumatol/tdueis. Epub 2022 Mar 30.